Low-molecular-weight heparin-conjugated liposomes with improved stability and hemocompatibility

Drug Delivery: Journal of Delivery and Targeting of Therapeutic Agents

Volumn 5, Issue 4, 1998, Pages 257-264

  Köse, Gamze Torun ^a   Arica, M Yakup ^a,b   Hasirci, Vasif ^a  

^a MIDDLE EAST TECHNICAL UNIVERSITY   (Turkey)

^b KIRIKKALE UNIVERSITY   (Turkey)

Author keywords

Conjugation; Hemocompatibility; Liposome Stability; Low Molecular Weight Heparin; Multilamellar Liposome

Indexed keywords

CHOLESTEROL; CYANAMIDE; LIPOSOME; LOW MOLECULAR WEIGHT HEPARIN; OCTADECYLAMINE; PHOSPHATIDYLCHOLINE; POTASSIUM FERRICYANIDE;

ARTICLE; BLOOD EXAMINATION; CALCIFICATION; CONTROLLED STUDY; DRUG CONJUGATION; DRUG HALF LIFE; DRUG STABILITY; DRUG STRUCTURE; HEMOLYSIS; HUMAN; HUMAN TISSUE; INFRARED SPECTROSCOPY; LIPID VESICLE; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; OSMOTIC FRAGILITY; PARTICLE SIZE; PLASMA; PRIORITY JOURNAL; RAMAN SPECTROMETRY;

EID: 2442764678     PISSN: 10717544     EISSN: None     Source Type: Journal    
DOI: 10.3109/10717549809065756     Document Type: Article

References (26)

1. Allen, T. M. 1981. A study of phospholipid interactions between high-density lipoproteins and small unilamellar vesicles. Biochim. Biophys. Acta 640(2): 385-397.
2. Allen, T. M. 1989. Stealth™liposomes: Avoiding reticuloendothelial uptake in liposomes. In Liposomes: The therapy of infectious diseases and cancer, eds. G. Lopez-Berestein and I. J. Fidler, 405, New York: Alan R. Liss.
3. Alving, C. R. 1991. Liposomes as carriers of antigens and adjuvants. J. Immunol. Methods 140(1):1-13.
4. Bounameaux, H., and Goldhaber, S. Z. 1995. Uses of low molecular heparin. Blood Rev. 9(4):213-219.
5. Byun, Y, Jacobs, H. A., and Kim, S. W. 1992. Binding kinetics of thrombin and antithrombin III with immobilized heparin using a spacer. ASAIO J. 38:M649-M653.
6. Gabizon, A., Catane, R., Uziely, B., Kaufman, B., Safra, T., Cohen, R., Martin, F., Huang, A., and Barenholz, Y. 1994. Prolonged circulation time and enhanced accumulation in malignant exudates of doxorubicin encapsulated in polyethyleneglycol coated liposomes. Cancer Res. 54(4):987-992.
7. Gabizon, A., Chemla, M., Tzemach, A., Horowitz, T., and Goren, D. 1996. Liposome longevity and stability in circulation: Effects on the in vivo delivery to tumors and therapeutic efficacy of encapsulated anthracyclines. J. Drug Targeting 3(5):391-398.
8. Green, D., Hirsh, J., Heit, J., Prins, M., Davidson, B., and Lensing, A. W. A. 1994. Low molecular weight heparin: A critical analysis of clinical trials. Pharmacol. Rev. 46(1):89-109.
9. Gregoriadis, G. 1995. Engineering liposomes for drug delivery: Progress and problems. Tibtech. 13:527-537.
10. Gregoriadis, G. 1995. In Stealth liposomes, eds. L. Lasic and F. Martin, 7-12. City: CPC Press.
11. Gregoriadis, G., Gürsel, I., Gürsel, M., and McCormack, B. 1996. Liposomes as immunological adjuvants and vaccine carriers. J. Controlled Release 41(1-2): 49-56.
12. Harashima, H., and Kiwada, H. 1996. Liposomal targeting and drug delivery: Kinetic consideration. Adv. Drug Delivery Rev. 19(3):425-444.
13. Hirsh, J. and Levine, M. N. 1994. Low molecular weight heparin: Laboratory properties and clinical evaluation. Eur J. Surg. S571:9-22.
14. Lasic, D. D. 1996. Liposomes. Sci. Med. 34-43.
15. Lasic, D. D., Martin, F. J., Gabzion, A., Huang, S. K., and Papahadjopoulos. D. 1991. Sterically stabilized liposomes: A hypothesis on the molecular origin of the extended circulation times. Biochim. Biophys. Acta 1070(1):187-192.
16. Liu, J., Pervin, A., Gallo, C. M., Desai, U. R., Von Corp, C. L., and Lindhardt, R. J., 1994. New approaches for the preparation of Hydrophobic heparin derivatives. J. Pharm. Sci. 83(7):1034-1039.
17. Li, S., Gao, X., Son, K., Sorgi, F., Hofland, H., and Huang, L. 1996. DC-Chol lipid system in gene transfer. J. Controlled Release 39(2-3):373-381.
18. Özden, M. Y., and Hasirci, V. N. 1990. Enzyme immobilization in polymer coated liposomes. Br. Polymer J. 23(3):29-234.
19. Özden, M. Y., and Hasirci, V. N. 1991. Preparation and characterization of polymer coated small unilamellar vesicles. Biochim. Biophys. Acta 1075(1): 102-108.
20. Senior, J. H. 1987. Fate and behaviour of liposomes in vivo: A review of controlling factors. CRC Crit. Rev. Ther. Drug Carrier Syst. 3(2):123-193.
21. Senior, J. H., Trimble, K. R., and Maskiewitz, R. 1991. Interaction of positively charged liposomes with blood: Implications for their applications in vivo. Biochim. Biophys. Acta 1070(1):173-179.
22. Torchilin, V. P., Berdichevsky, V. R., Barsukov, A. A., and Smirnov, V. N. 1980. Coating liposomes with protein decreases their capture by macrophages. FEBS Lett. 111(1):184-188.
23. Torchilin, V. P., Omelyanenko, V. G., Papisov, M. I., Bogdanov, A. A., Trubetskoy, V. S., Herron, J. N., and Gentry, C. A. 1994. Poly(ethylene glycol) on the liposome surface: On the mechanism of polymer coated liposome longevity. Biochim. Biophys. Acta 1195(1):11-20.
24. Woodle, M. C., and Papahadjopoulos, D. 1988. Liposome preparation and size characterization. Methods in Enzymol. 171:193-217.
25. Woodle, M. C., and Lasic, D. L. 1992. Sterically stabilized liposomes. Biochim. Biophys. Acta 1113(2):171-199.
26. Zalipsky, S., Hansen, C. B., Oaks, J. M., and Allen, T. M. 1996. Evaluation of blood clearance rates and biodistribution of poly(2-oxazoline)-grafted liposomes. J. Pharmaceut. Sci. 85(2):133-137.